115 related articles for article (PubMed ID: 33217622)
1. Prescribing patterns and outcomes of venous thromboembolism prophylaxis in hospitalized medical and cancer patients: Observations from the Ottawa Hospital.
Budd AC; Rhodes M; Forster AJ; Noghani P; Carrier M; Wells PS
Thromb Res; 2021 Jan; 197():144-152. PubMed ID: 33217622
[TBL] [Abstract][Full Text] [Related]
2. Hospital performance for pharmacologic venous thromboembolism prophylaxis and rate of venous thromboembolism : a cohort study.
Flanders SA; Greene MT; Grant P; Kaatz S; Paje D; Lee B; Barron J; Chopra V; Share D; Bernstein SJ
JAMA Intern Med; 2014 Oct; 174(10):1577-84. PubMed ID: 25133488
[TBL] [Abstract][Full Text] [Related]
3. Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: a review.
Huo MH; Muntz J
Clin Ther; 2009 Jun; 31(6):1129-41. PubMed ID: 19695383
[TBL] [Abstract][Full Text] [Related]
4. Bleeding and venous thromboembolic events in patients with active cancer hospitalized for an acute medical illness.
Di Nisio M; Candeloro M; Rutjes AWS; Galli V; Tritto M; Porreca E
Thromb Res; 2018 Sep; 169():44-49. PubMed ID: 30015227
[TBL] [Abstract][Full Text] [Related]
5. Venous thromboembolism prophylaxis for medical service-mostly cancer-patients at hospital discharge.
Fanikos J; Rao A; Seger AC; Piazza G; Catapane E; Chen X; Goldhaber SZ
Am J Med; 2011 Dec; 124(12):1143-50. PubMed ID: 22114828
[TBL] [Abstract][Full Text] [Related]
6. Thromboprophylaxis patterns, risk factors, and outcomes of care in the medically ill patient population.
Mahan CE; Fisher MD; Mills RM; Fields LE; Stephenson JJ; Fu AC; Spyropoulos AC
Thromb Res; 2013 Nov; 132(5):520-6. PubMed ID: 24080150
[TBL] [Abstract][Full Text] [Related]
7. Pattern of frequent but nontargeted pharmacologic thromboprophylaxis for hospitalized patients with cancer at academic medical centers: a prospective, cross-sectional, multicenter study.
Zwicker JI; Rojan A; Campigotto F; Rehman N; Funches R; Connolly G; Webster J; Aggarwal A; Mobarek D; Faselis C; Neuberg D; Rickles FR; Wun T; Streiff MB; Khorana AA
J Clin Oncol; 2014 Jun; 32(17):1792-6. PubMed ID: 24799475
[TBL] [Abstract][Full Text] [Related]
8. Formal and informal venous thromboembolism risk assessment and impact on prescribing of thromboprophylaxis: a retrospective cohort study.
Kemp M; Chan AHY; Harrison J; Rogers H; Zhao A; Kaur H; Tang G; Yang E; Beyene K
Int J Clin Pharm; 2023 Aug; 45(4):864-874. PubMed ID: 37074512
[TBL] [Abstract][Full Text] [Related]
9. Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients. A retrospective multicenter study.
Nieto JA; Cámara T; Camacho I;
Eur J Intern Med; 2014 Oct; 25(8):717-23. PubMed ID: 25091470
[TBL] [Abstract][Full Text] [Related]
10. Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative.
Barkoudah E; Piazza G; Hecht TEH; Grant P; Deitelzweig S; Fang MC; Fanikos J; Kao CK; Barnes GD; Chen T; Ramishvili T; Schnipper JL; Goldstein JN; Ruff CT; Kaatz S; Schwartz A; Connors JM; Goldhaber SZ
Am J Med; 2020 May; 133 Suppl 1():1-27. PubMed ID: 32362349
[TBL] [Abstract][Full Text] [Related]
11. Inpatient prophylaxis in cancer patients: where is the evidence?
Patell R; Zwicker JI
Thromb Res; 2020 Jul; 191 Suppl 1():S85-S90. PubMed ID: 32736785
[TBL] [Abstract][Full Text] [Related]
12. Appropriate thromboprophylaxis in hospitalized cancer patients.
Amin A; Stemkowski S; Lin J; Yang G
Clin Adv Hematol Oncol; 2008 Dec; 6(12):910-20. PubMed ID: 19209141
[TBL] [Abstract][Full Text] [Related]
13. Real-life use of thromboprophylaxis in patients hospitalized for pulmonary disorders: A single-center retrospective study.
Łukaszuk RF; Plens K; Undas A
Adv Clin Exp Med; 2018 Feb; 27(2):237-243. PubMed ID: 29521068
[TBL] [Abstract][Full Text] [Related]
14. Retrospective evaluation of venous thromboembolism prophylaxis in the adult cancer population.
Reeves D; Liu CY
J Oncol Pharm Pract; 2010 Mar; 16(1):27-31. PubMed ID: 19401307
[TBL] [Abstract][Full Text] [Related]
15. Venous thromboembolism in cancer patients.
Deng A; Galanis T; Graham MG
Hosp Pract (1995); 2014 Dec; 42(5):24-33. PubMed ID: 25485915
[TBL] [Abstract][Full Text] [Related]
16. Insights into venous thromboembolism prevention in hospitalized cancer patients: Lessons from a prospective study.
Figueroa R; Alfonso A; López-Picazo J; Gil-Bazo I; García-Mouriz A; Hermida J; Páramo JA; Lecumberri R
PLoS One; 2018; 13(8):e0200220. PubMed ID: 30071038
[TBL] [Abstract][Full Text] [Related]
17. A retrospective review of the use of thromboprophylaxis in patients who subsequently developed a venous thromboembolism after discharge from hospital.
Wiseman DN; Harrison J
N Z Med J; 2010 Feb; 123(1309):37-49. PubMed ID: 20186241
[TBL] [Abstract][Full Text] [Related]
18. Extended thromboprophylaxis in the acutely ill medical patient after hospitalization - a paradigm shift in post-discharge thromboprophylaxis.
Mahan CE; Burnett AE; Fletcher ML; Spyropoulos AC
Hosp Pract (1995); 2018 Feb; 46(1):5-15. PubMed ID: 29171776
[TBL] [Abstract][Full Text] [Related]
19. Prophylactic anticoagulation for venous thromboembolism in hospitalized cirrhosis patients is not associated with high rates of gastrointestinal bleeding.
Intagliata NM; Henry ZH; Shah N; Lisman T; Caldwell SH; Northup PG
Liver Int; 2014 Jan; 34(1):26-32. PubMed ID: 23758818
[TBL] [Abstract][Full Text] [Related]
20. Clinical impact of application of risk assessment models (Padua Prediction Score and Improve Bleeding Score) on venous thromboembolism, major hemorrhage and health expenditure associated with pharmacologic VTE prophylaxis: a "real life" prospective and retrospective observational study on patients hospitalized in a Single Internal Medicine Unit (the STIME study).
Depietri L; Marietta M; Scarlini S; Marcacci M; Corradini E; Pietrangelo A; Ventura P
Intern Emerg Med; 2018 Jun; 13(4):527-534. PubMed ID: 29502330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
